Mesenchymal stem cells (MSC) have become a promising tool for therapeutic intervention.
Their unique features, including self-renewal, multipotency and immunomodulatory …

Around 5 million annual births in EU and 131 million worldwide give a unique opportunity to
collect lifesaving Wharton's jelly derived mesenchymal stem cells (WJ‐MSC). Evidences that …

Type 1 diabetes mellitus (T1D) is a chronic, multifactorial autoimmune disease that involves
the progressive destruction of pancreatic β-cells, ultimately resulting in the loss of insulin …

Human bone marrow-derived mesenchymal stem/stromal cells (BM-MSCs) represent
promising stem cell therapy for the treatment of type 2 diabetes mellitus (T2DM), but the …

Metabolic syndrome (MetS) is highly associated with a modern lifestyle. The prevalence of
MetS has reached epidemic proportion and is still rising. The main cause of MetS and finally …

Human bone marrow-derived mesenchymal stromal cells (MSCs) have been investigated in
numerous disease settings involving impaired regeneration because of the crucial role they …

Mesenchymal stem cells (MSCs) have already made their mark in the young field of
regenerative medicine. Easily derived from many adult tissues, their therapeutic worth has …

Generation of surrogate β-cells is the need of the day to compensate the short supply of
islets for transplantation to diabetic patients requiring daily shots of insulin. Over the years …

Background aims. The scarcity of human islets for transplantation remains a major limitation
of cell replacement therapy for diabetes. Bone marrow-derived progenitor cells are of …

Background aims Adipose-derived stem cells (ASCs) represent an important source of cell
therapy to treat diabetic complications. However, hyperglycemia may alter several cellular …